1887

Journal of General Virology header logo

Volume 67, Issue 8

Biological Activities and Receptor Binding of Two Human Recombinant Interferons and their Hybrids Free

Abstract

Summary

Two human recombinant lymphoblastoid interferon-α subtypes, LyIFN-B (α) and LyIFN-D (α), and 10 hybrids generated therefrom were produced in and purified. The antiviral and antiproliferative activities and the induction of (2′–5′)oligoadenylate synthetase were compared to their receptor binding affinities. The IFN subtypes and their hybrids had similar specific antiviral activities on bovine cells. On human cells both the specific antiviral and antiproliferative activities of LyIFN-B were about 30-fold higher than those of LyIFN-D. This difference in activity could be attributed partly to the N-terminal amino acids 1 to 60 and partly to amino acids 61 to 92. A third domain affecting the biological activities was found within the carboxy-proximal segment from amino acids 93 to 150. The differences in these activities were found to correlate with their ability to bind the receptor, suggesting that the differences in activity might be due to altered binding of the IFNs to the cellular receptors. In contrast, the induction of (2′–5′)oligoadenylate synthetase did not follow the same activity profile. On mouse cells, the efficiency of the hybrids was affected by at least four sites on the IFN protein. A hybrid with the N-terminal segment 1 to 60 from IFN-B and amino acids 61 to 166 from IFN-D had a specific antiviral activity on mouse cells as high as on human cells corresponding to a 500- and 5000-fold increase in specific activity compared to IFN-D and IFN-B, respectively. We suggest that on mouse cells the IFN activity may be more dependent on conformational differences than on human cells, which in turn might reflect a less precise fit to the mouse receptor than to the human receptor.

  • Received:
  • Accepted:
  • Published Online:
Keyword(s): (2′–5′)oligoadenylate synthetase , interferon (HuIFN-α) and receptor binding
© Journal of General Virology 1986
Loading

Article metrics loading...

/content/journal/jgv/10.1099/0022-1317-67-8-1633
1986-08-01
2024-04-30
Loading full text...

Full text loading...

/deliver/fulltext/jgv/67/8/JV0670081633.html?itemId=/content/journal/jgv/10.1099/0022-1317-67-8-1633&mimeType=html&fmt=ahah

References

  1. Aguet M. 1980; High-affinity binding of 125I-labelled mouse interferon to a specific cell surface receptor. Nature, London 284:459–461
     [Google Scholar]
  2. Aguet M., Gresser I., Hovanessian A. G., Bandu M. T., Blanchard B., Blangy D. 1981; Specific high-affinity binding of 125I-labeled mouse interferon to interferon resistant embryonal carcinoma cells in vitro. Virology 114:585–588
     [Google Scholar]
  3. Aguet M., Gröbke M., Dreiding P. 1984; Various human interferon-α subclasses cross-react with common receptors: their binding affinities correlate with their specific biological activities. Virology 132:211–216
     [Google Scholar]
  4. Alkan S. S., Weideli H. J., Schurch A. R. 1983; Monoclonal antibodies against human leukocyte interferons for a definition of subclasses and their affinity purification. In Protides of Biological Fluids vol 30 pp 495–498 Edited by Peeters H. Oxford: Pergamon Press;
     [Google Scholar]
  5. Bradford M. M. 1976; A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Analytical Biochemistry 72:248–254
     [Google Scholar]
  6. Dron M., Tovey M. G. 1983; Isolation of Daudi cells with reduced sensitivity to interferon. I. Characterization. Journal of General Virology 64:2641–2647
     [Google Scholar]
  7. Fellous M., Kamoun M., Gresser I., Bono R. 1979; Enhanced expression of HLA antigens and β2, - microglobulin on interferon-treated human lymphoid cells. European Journal of Immunology 9:446–452
     [Google Scholar]
  8. Goeddel D. V., Sheppard H. M., Yelverton E-., Leung D. W., Crea R., Sloma A., Pestka S. 1980; Synthesis of human fibroblast interferon by E. coli. Nucleic Acids Research 8:4057–4074
     [Google Scholar]
  9. Goeddel D. V., Leung D. W., Dull T. J., Gross M., Lawn R. M., Mccandliss R., Seeburg P. H., Ullrich A., Yelverton E., Gray P. W. 1981; The structure of eight distinct cloned human leukocyte interferon cDNAs. Nature, London 290:20–26
     [Google Scholar]
  10. Goren T., Kapitkovsky A., Kimchi A., Rubinstein M. 1983; High and low potency interferon-a subtypes induce (2'– 5′) oligoadenylate synthetase with similar efficiency. Virology 130:273–280
     [Google Scholar]
  11. Heron I., Hokland M., Berg K. 1978; Enhanced expression of β2-microglobulin and HLA antigens on human lymphoid cells by interferon. Proceedings of the National Academy of Sciences, U.S.A. 75:6215–6219
     [Google Scholar]
  12. Kerr I. M., Brown R. E. 1978; pppA2′p5′A2′p5′A: an inhibitor of protein synthesis synthesized with an enzyme fraction from interferon treated cells. Proceedings of the National Academy of Sciences, U.S.A. 75:256–260
     [Google Scholar]
  13. Klein E., Klein G., Nadkarni J. S., Nadkarni J. J., Wigzell H., Clifford P. 1968; Surface IgM kappa specificity on a Burkitt lymphoma cell in vivo and in derived culture lines. Cancer Research 28:1300–1310
     [Google Scholar]
  14. Marti J., Vandenbussche P., Silhol M., Milhaud P., Verhaegen M., Content J., Lebleu B. 1981; Effects of interferon on sensitive and resistant LI 210 cell lines. Journal of Interferon Research 1:287–295
     [Google Scholar]
  15. Masucci M. G., Szigetl R., Klein E., Klein G., Gruest J., Montagnier L., Taira H., Hall A., Nagata S., Weissmann C. 1980; Effect of interferon-αl from E. coli on some cell functions. Science 209:1431–1435
     [Google Scholar]
  16. Merlin G., Revel M., Wallach D. 1981; The interferon-induced enzyme oligoisoadenylate synthetase: rapid determination of its in vitro products. Analytical Biochemistry 110:190–196
     [Google Scholar]
  17. Mogensen K. E., Bandu M.-T. 1983; Kinetic evidence for an activation step following binding of human interferon-a2 to the membrane receptors of Daudi cells. European Journal of Biochemistry 134:355–364
     [Google Scholar]
  18. Nagata S., Mantei N., Weissmann C. 1980; The structure of one of the eight or more distinct chromosomal genes for human interferon-a. Nature, London 287:401–408
     [Google Scholar]
  19. Rehberg E., Kelder B., Hoal E. G., Pestka S. 1982; Specific molecular activities of recombinant and hybrid leukocyte interferons. Journal of Biological Chemistry 257:11497–11502
     [Google Scholar]
  20. Rink H., Liersch M., Sieber P., Meyer F. 1984; A large fragment approach to DNA synthesis: total synthesis of a gene for the protease inhibitor eglin c from the leech Hirudo medicinalis and its expression in E. coli. Nucleic Acids Research 12:6369–6287
     [Google Scholar]
  21. Sanger F., Coulson A. R. 1975; A rapid method for determining sequences in DNA by primed synthesis with DNA polymerase. Journal of Molecular Biology 94:441–448
     [Google Scholar]
  22. Schmidt A., Chernajovsky Y., Shulman L., Federman P., Berissi H., Revel M. 1979; An interferon induced phosphodiesterase degrading (2′–5′) oligoisoadenylate and the C-C-A terminus of tRNA. Proceedings of the National Academy of Sciences, U.S.A. 76:4788–4792
     [Google Scholar]
  23. Sen G. C., Herz R., Davatelis V., Pestka S. 1984; Antiviral and protein inducing activities of recombinant human leukocyte interferons and their hybrids. Journal of Virology 50:445–450
     [Google Scholar]
  24. Staehelin T., Hobbs D. S., Kung H.-F., Lai C.-Y., Pestka S. 1981; Purification and characterization of recombinant human leukocyte interferon (IFLrA) with monoclonal antibodies. Journal of Biological Chemistry 256:9750–9754
     [Google Scholar]
  25. Streuli M., Hall A., Boll W., Stewart W. E. II, Nagata S., Weissmann C. 1981; Target cell specificity of two species of human interferon-a produced in Escherichia coli and of hybrid molecules derived from them. Proceedings of the National Academy of Sciences, U.S.A. 78:2848–2852
     [Google Scholar]
  26. Uzé G., Mogensen K. E., Aguet M. 1985; Receptor dynamics of closely related ligands: ‘fast’ and ‘slow’ interferons. EMBO Journal 4:65–70
     [Google Scholar]
  27. Weck P. K., Apperson S., Stebbing N., Gray P. W., Leung D., Shepard M. H., Goeddel D. V. 1981; Antiviral activities of hybrids of two major human leukocyte interferons. Nucleic Acids Research 9:6153–6166
     [Google Scholar]
  28. Zilberstein A., Kimchi A., Schmidt A., Revel M. 1978; Isolation of two interferon-induced translational inhibitors: a protein kinase and an oligoisoadenylate synthetase. Proceedings of the National Academy of Sciences, U.S.A. 75:4734–1738
     [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/0022-1317-67-8-1633
Loading
Biological Activities and Receptor Binding of Two Human Recombinant Interferons and their Hybrids
J. Gen. Virol. 67, 1633 (1986); https://doi.org/10.1099/0022-1317-67-8-1633
/content/journal/jgv/10.1099/0022-1317-67-8-1633
/content/journal/jgv/10.1099/0022-1317-67-8-1633
Loading

Data & Media loading...

Most cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error